<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03946267</url>
  </required_header>
  <id_info>
    <org_study_id>11/2016</org_study_id>
    <nct_id>NCT03946267</nct_id>
  </id_info>
  <brief_title>Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis.</brief_title>
  <official_title>Infracyanine Green vs Brilliant Blue G in Inverted Flap Surgery for Medium to Large Macular Holes: A Swept Source OCT Analysis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare by swept-source optical coherence tomography (SS-OCT) the retinal
      morphology after inverted internal limiting membrane (I-ILM) flap vitreoretinal surgery for
      medium-to-large macular holes using infracyanine green (IFCG) vs brilliant blue G (BBG)
      dyeing. It is a single-center prospective, randomized study. One group of patients will
      undergo I-ILM vitrectomy with IFCG staining, the other vitrectomy with BBG staining.
      Postoperative twelve-month corrected distance visual acuity, macular hole closure rate, and
      SS-OCT parameters will be compared and statistically analyzed. The aim of the study is to
      verify if these parameters can be negatively affected by toxicity related to the use of one
      of the two dyes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to compare by swept-source optical coherence tomography (SS-OCT)
      the retinal morphology after inverted internal limiting membrane flap (I-ILM) surgery for
      medium-to-large macular holes (FTMHs) using infracyanine green (IFCG) vs brilliant blue G
      (BBG). This prospective randomized study include 40 eyes with ≥ 400 µ idiopathic FTMH
      undergoing IFCG or BBG-stained I-ILM technique. Just before surgery, randomization is
      performed using the sealed-envelope technique, based on the patients' surgical chart number.
      The random allocation sequence is generated by the trial statistician pulling 41
      standard-sized pieces of paper out of a hat. Twenty pieces of paper are marked with the
      Letter I, for IFCG, and 21 with the Letter B, for BBG. The trial statistician then
      sequentially puts each piece of paper into 41 sealed opaque envelopes. These envelopes are
      numbered 1 to 41 and given to the surgeons. Patients are numbered randomly from 1 to 41 based
      on a surgical chart number related to the baseline testing session and intervention period.
      Clinical data collection and measurement of outcome variables are performed by personnel
      masked to the randomization process and not been directly involved in the patients' surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 9, 2018</start_date>
  <completion_date type="Actual">August 23, 2018</completion_date>
  <primary_completion_date type="Actual">July 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients assigned to undergo inverted flap surgery with infracyanine green or with brilliant blue G using the sealed-envelope randomization technique. The interventional study model consists of a randomized controlled trial study design.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Authors involved in clinical data collection and measurement of outcome variables are not been directly involved in the patients' surgery and are masked to the randomization process</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative macular hole closure rate and morphology</measure>
    <time_frame>twelve months</time_frame>
    <description>Evaluated by swept-source OCT (Topcon DRI OCT Triton Series)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative mean corrected distance visual acuity</measure>
    <time_frame>twelve months</time_frame>
    <description>measured in logMAR notation using Early Treatment of Diabetic Retinopathy Study charts (CC-100XP LCD System for ETDRS Chart display)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative sizes of ellipsoid zone (EZ) and external limiting membrane (ELM) defects</measure>
    <time_frame>twelve months</time_frame>
    <description>Measured in micrometers by three-dimensional (3D) volumetric scan with swept-source OCT (Topcon DRI OCT Triton Series)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thickness maps of the 1 mm central foveal thickness; second 3-mm grid including parafoveal macular area; second and the third 6-mm grid including parafoveal and perifoveal ganglion cells and inner plexiform layer; peripapillary nerve fiber layer.</measure>
    <time_frame>twelve months</time_frame>
    <description>Measured in micrometers by auto-segmentation software (Topcon Advanced Boundary Software - TABSTM)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Macular Holes</condition>
  <arm_group>
    <arm_group_label>IFCG = Infracyanine Green stained eyes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After removal of core and posterior cortical vitreous and hyaloid stained with 0.2 ml triamcinolone acetonide 40 mg/mL, on the basis of the previous randomization the ILM is stained with 0.2 ml of low-concentration (0.5 mg/mL, 0.05%) IFCG injected over the macular area with the infusion line closed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BBG = Brilliant Peel stained eyes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After removal of core and posterior cortical vitreous and hyaloid stained with 0.2 ml triamcinolone acetonide 40 mg/mL, on the basis of the previous randomization the ILM is stained with 0.2 mL BBG at a concentration of 0.25 mg/mL (0.025%) injected over the macular area with the infusion line closed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inverted inner limiting membrane flap technique for large full thickness macular holes</intervention_name>
    <description>The ILM, stained with IFCG or BBG, is peeled off with ILM forceps, usually beginning near the inferotemporal vascular arcade, at least 2 disk diameters from the macular hole, in a circular manner. The peeling is extended up to the edges of the macular hole, the wide ILM flap obtained reduced by trimming with the vitreous cutter, and the annular remnant of ILM hinged to the hole's edge gently inverted upside down facing the RPE. Therefore, the hole is covered with usually more layers of inverted ILM. Attention is paid to avoid insertion and filling of the hole volume with ILM.</description>
    <arm_group_label>BBG = Brilliant Peel stained eyes</arm_group_label>
    <arm_group_label>IFCG = Infracyanine Green stained eyes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Phakic or pseudophakic patients affected with medium to large idiopathic full
             thickness macular hole (FTMH), with a minimum preoperative diameter of 400 µ

        Exclusion Criteria:

          -  Patients with chorioretinal diseases except FTMH, myopia &gt; 5 D, history of glaucoma,
             previous trauma or ocular surgery other than cataract extraction, or conditions
             affecting visual acuity except cataract.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salvatore Cillino, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AOUP Paolo Giaccone, Palermo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Michalewska Z, Michalewski J, Adelman RA, Nawrocki J. Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology. 2010 Oct;117(10):2018-25. doi: 10.1016/j.ophtha.2010.02.011. Epub 2010 Jun 11.</citation>
    <PMID>20541263</PMID>
  </reference>
  <reference>
    <citation>Haritoglou C, Tadayoni R, May CA, Gass CA, Freyer W, Priglinger SG, Kampik A. Short-term in vivo evaluation of novel vital dyes for intraocular surgery. Retina. 2006 Jul-Aug;26(6):673-8.</citation>
    <PMID>16829811</PMID>
  </reference>
  <reference>
    <citation>Schmid-Kubista KE, Lamar PD, Schenk A, Stolba U, Binder S. Comparison of macular function and visual fields after membrane blue or infracyanine green staining in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol. 2010 Mar;248(3):381-8. doi: 10.1007/s00417-009-1213-4. Epub 2009 Oct 13.</citation>
    <PMID>19823863</PMID>
  </reference>
  <reference>
    <citation>Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology. 2000 Nov;107(11):2010-4.</citation>
    <PMID>11054324</PMID>
  </reference>
  <reference>
    <citation>Iriyama A, Uchida S, Yanagi Y, Tamaki Y, Inoue Y, Matsuura K, Kadonosono K, Araie M. Effects of indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis Sci. 2004 Mar;45(3):943-7.</citation>
    <PMID>14985315</PMID>
  </reference>
  <reference>
    <citation>Baba T, Hagiwara A, Sato E, Arai M, Oshitari T, Yamamoto S. Comparison of vitrectomy with brilliant blue G or indocyanine green on retinal microstructure and function of eyes with macular hole. Ophthalmology. 2012 Dec;119(12):2609-15. doi: 10.1016/j.ophtha.2012.06.048. Epub 2012 Aug 24.</citation>
    <PMID>22921387</PMID>
  </reference>
  <reference>
    <citation>Park JH, Lee SM, Park SW, Lee JE, Byon IS. Comparative analysis of large macular hole surgery using an internal limiting membrane insertion versus inverted flap technique. Br J Ophthalmol. 2019 Feb;103(2):245-250. doi: 10.1136/bjophthalmol-2017-311770. Epub 2018 Apr 2.</citation>
    <PMID>29610221</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 9, 2019</study_first_submitted>
  <study_first_submitted_qc>May 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2019</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo</investigator_affiliation>
    <investigator_full_name>Salvatore Cillino</investigator_full_name>
    <investigator_title>Head of the Ophthalmology Section of the Department of Biomedicine, Neurosciences and Advanced Diagnostic</investigator_title>
  </responsible_party>
  <keyword>Large macular hole</keyword>
  <keyword>Inverted flap surgery</keyword>
  <keyword>Infracyanine green</keyword>
  <keyword>Brilliant blue G</keyword>
  <keyword>Swept source OCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

